StudySetGo Trials designs and runs the study — but the right study depends on what you’re trying to unlock. Find your situation below to see what we recommend and how we deliver it.
Click your situation to see what StudySetGo Trials recommends and how we deliver it.
Buyers at H&B, Boots, and major grocers want published evidence before they range a product.
Click to see what you need →Investors want de-risked science before they write a cheque. Evidence turns scepticism into conviction.
Click to see what you need →Ad suspensions, ASA notices, or a compliance review. Evidence is the fastest route to solid ground.
Click to see what you need →Your category is maturing. The brands with published studies will own the “proven” position.
Click to see what you need →A B2B partner or healthcare channel has made clinical validation a condition of working together.
Click to see what you need →Customers and HCPs are asking for proof. You have ingredient data — but not a study of your own.
Click to see what you need →Not sure which applies to you? A discovery call takes 30 minutes and ends with a clear recommendation.
Book a free discovery call →These aren’t gatekeeping questions. They’re the things that determine your study design, your sample size, your cost, and your timeline. If any answer is “not yet”, the discovery call is where we work it out.
You need to know exactly what you want to prove before designing a study. “We want to show it works” isn’t a primary endpoint. The specific claim determines the outcome measure, which determines the study design, which determines the cost. Vague claims lead to vague endpoints and data you can’t use in marketing.
At the discovery call: we help you translate your marketing claims into measurable study endpoints.
A study on v1.2 doesn’t protect v1.3. If your formulation changes after a study — different dose, different carrier, different ingredient grade — the evidence no longer maps to the product you’re selling. Before committing to a full RCT, your formulation needs to be final.
If you’re not sure: a pilot study is the right first step. Run the pilot on what you have, learn from the data, finalise the formulation, then design the full RCT.
DTC with general wellbeing claims has a different evidence threshold to a Boots buyer pitch or an NHS-adjacent healthcare channel. Knowing where you want to use the evidence shapes how we design the study — the outcome measure, the journal target, and the way results are packaged for different audiences.
At the discovery call: we align the study design to your commercial objectives, not just the science.
StudySetGo Trials projects typically range from £35,000–£90,000 depending on study design, sample size, duration, and outcome measures. Billing is milestone-based: 80% at protocol sign-off, 10% at ethics approval, 10% at data delivery — so you never pay the full amount until the study is delivered. We scope the full cost at the discovery call before you commit to anything.
In most cases, yes. Ingredient studies test a single compound at a controlled dose in a specific population — often a pharmaceutical-grade isolate. Your finished product has a different formulation, dose, delivery format, and matrix. Regulators, retail buyers, and investors want evidence on your product, not on an ingredient someone else studied a decade ago. The same caveat applies to competitor studies or category-level research.
Yes — and we often recommend it. A pilot study (typically 15–30 participants, 4–8 weeks) gives you exploratory efficacy data, proof of concept for investors, and a foundation for the full study design. If the pilot is strong, you proceed to the RCT with confidence. If it surfaces issues — a compliance problem, a dosing question, a recruitment signal — you address them cheaply before committing to a larger trial. The pilot cost is not wasted; it feeds directly into the RCT design.
You receive the raw data, a full statistical analysis report, and a publication-ready manuscript prepared for peer-reviewed journal submission. You also receive a one-page results summary formatted for use in marketing, sales decks, and retail presentations. Everything is yours — you own the data and control all publication decisions.
Universities can take 6–12 months just to process a research contract before a study starts. Research teams operate on academic calendars, not commercial ones — they have lab schedules, student projects, and grant cycles that have nothing to do with your go-to-market timeline. Universities also typically retain publication rights, meaning they can publish results even if they’re unfavourable. StudySetGo Trials runs the study directly: independent ethics committees, our own recruitment infrastructure, your timeline, your data.
With our independent ethics board partners, approval typically takes 3–5 weeks. This compares to 3–6 months through NHS RECs or university ethics committees. Ethics approval is often the biggest bottleneck in traditional research pathways — removing it is one of the biggest commercial advantages of working with StudySetGo Trials.
No. We work with brands globally. Our participant network and ethics infrastructure is UK-based, and we run remote-first trials that don’t require participants to travel to a lab. Outcome measures are validated for remote collection — devices ship to participants, data uploads digitally. As long as your product can be shipped to UK participants, we can run your study.
The discovery call is free, takes 30 minutes, and ends with a clear recommendation — study type, scope, and a realistic timeline. No obligation to proceed.